M. Bel

发表

SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021—Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing

A. Trkola, L. Risch, S. Yerly, 2021, Microorganisms.

SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing

Stephen L. Leib, A. Trkola, L. Risch, 2021 .

Influenza Vaccination Given at Least 2 Weeks Before Delivery to Pregnant Women Facilitates Transmission of Seroprotective Influenza-specific Antibodies to the Newborn

C. Combescure, G. Blanchard-Rohner, C. Siegrist, 2013, The Pediatric infectious disease journal.

A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.

C. Combescure, A. Hottinger, L. Kaiser, 2012, The oncologist.

Strong serological responses and HIV RNA increase following AS03‐adjuvanted pandemic immunization in HIV‐infected patients

S. Yerly, B. Hirschel, C. Combescure, 2012, HIV medicine.

Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.

C. Combescure, L. Kaiser, A. L'Huillier, 2011, Vaccine.

Hemagglutinin-Dependent Tropism of H5N1 Avian Influenza Virus for Human Endothelial Cells

K. McCullough, N. Ruggli, Y. Sakoda, 2009, Journal of Virology.

Efficient Sensing of Avian Influenza Viruses by Porcine Plasmacytoid Dendritic Cells

K. McCullough, M. Matrosovich, A. Summerfield, 2011, Viruses.

PCR performance in the SARS-CoV-2 Omicron variant of concern?

A. Egli, H. Seth-Smith, T. Roloff, 2021, Swiss medical weekly.

Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease

C. Siegrist, K. Posfay-Barbe, M. Schäppi, 2012, Journal of pediatric gastroenterology and nutrition.

Responses of Solid Organ Transplant Recipients to the As03-Adjuvanted Pandemic Influenza Vaccine

C. Combescure, T. Berney, P. Soccal, 2012, Antiviral therapy.

Higher Memory Responses in HIV-Infected and Kidney Transplanted Patients than in Healthy Subjects following Priming with the Pandemic Vaccine

S. Yerly, B. Hirschel, C. Combescure, 2012, PloS one.

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

C. Combescure, J. Passweg, L. Kaiser, 2011, Haematologica.

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.

C. Combescure, C. Gabay, P. Guerne, 2011, Arthritis and rheumatism.

Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.

C. Howald, I. Xenarios, K. Harshman, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.